Skip to main content
Clinical Trials/CTRI/2023/05/053173
CTRI/2023/05/053173
Not Yet Recruiting
Phase 2

A pilot study to evaluate the efficacy and safety of low carb DiabeSmart Atta Additive DiabeSmart South Indian Mixture and DiabeSmart Ultra-low carb atta in lowering hyperglycemia in comparison with standard carbohydrate diet among diabetics and pre diabetics.

Bajo Foods Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Bajo Foods Pvt Ltd
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Bajo Foods Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Male and female subjects aged 30\-55 years both inclusive.
  • 2\.Subjects with history of prediabetes (5\.7\-6\.4%) and Diabetes mellitus â?? type II for 1\-15 years.
  • 3\.Diabetics with HbA1c \>7\.5%

Exclusion Criteria

  • 1\.History of hypersensitivity to any of the study treatments, excipients, or drugs of similar chemical classes including sulfonylureas and meglitinides
  • 2\.History of type 1 diabetes
  • 3\.Subjects on insulin therapy
  • 4\.Subjects with the history of uncontrolled hypertension and/or hyperthyroidism
  • 5\.History of alcoholism
  • 6\.Subjects with psychiatric or neurological disability or mental health disorder
  • 7\.Subjects with serious health conditions such as cardiac disease, renal dysfunction, and cancers.
  • 8\.Female subjects who are pregnant or had planned for pregnancy in the following months or were breast\-feeding.
  • 9\.Subjects who refuse to sign informed consent.
  • 10\.Those who have participated in another clinical trial within 1 month of visit 1 or plan to participate during the clinical trial period.

Outcomes

Primary Outcomes

Not specified

Similar Trials